Laparoscopy remains the gold standard for diagnosis and treatment of the disease.
Endometriosis is a poorly understood condition in which endometrial-like–tissue implants outside the uterus. The disease affects 10% of reproductive-age women and 90% of patients with chronic pelvic pain and infertility.1 The mechanism of implantation and associated pain development is still incompletely described.1 Stage and pain do not correlate well because pelvic pain can be inflammatory and neuropathic in nature, with a component of central sensitization of the nervous system.1 Patients with pelvic pain exhibit enhanced anterior insula glutamatergic neurotransmission and connectivity with the prefrontal cortex, meaning that even with full excision of disease, pain may persist.2
Although expert opinion suggests that early diagnosis of endometriosis is key, diagnostic challenges in combination with the requirement for a surgical procedure for diagnosis contribute to a significant delay in treatment. In 2008, US health care costs for endometriosis were estimated at $4000 annually per affected patient.1 Delays in surgical diagnosis are thought to contribute to this high cost because patients without answers seek further care and expensive testing.
Endometriosis can have serious effects on patients’ quality of life and fertility, leading to lost wages and lack of productivity. The average delay in diagnosis is approximately
7 years, preventing early treatment that can reduce chronic pain and stress on mental and emotional health.3
One must remember that chronic pelvic pain can be multifactorial, so a comprehensive evaluation for all causes of the disease must be undertaken, not only gynecologic causes, but also other organ systems, including musculoskeletal, gastrointestinal, genitourinary, and psychological. Infectious diseases as well as immunological diseases, in which the contribution to pain is more poorly understood, must also be considered. Many of these can be identified using a careful history and physical to identify a “source” organ and
through imaging.
Because of the range of etiologies for pelvic pain, a broader work-up should always be performed to rule out other causes. However, when endometriosis is suspected, further action should be taken. Although advances in imaging (eg, MRI and gel-contrast dynamic ultrasound) and the development of predictive algorithms might help with a clinical diagnosis of endometriosis, no current technology can predict all stages of the disease.4 Laparoscopy for endometriosis began in the 1970s and remains the gold standard for diagnosis and treatment of endometriosis.
Given that medical therapies are generally well tolerated, most national organizations recommend a trial of medical therapy to give patients a shorter time to pain relief. Studies have shown that combined hormonal contraceptives, progestins, and gonadotropin-releasing hormone agonists are very effective at reducing pain related to endometriosis.5
However, the study authors recommend having a low threshold for surgical evaluation. For persistent pain despite a short course of medical therapy (3-6 months), surgical therapy and reevaluation of other causes of pelvic pain is indicated.
Careful patient assessment, physical examination findings, and imaging can help guide surgical management. Structural abnormalities such as adenomyosis, ovarian endometriomas, and deeply infiltrating endometriosis nodules indicate advanced disease and should expedite surgical referrals.
A comprehensive discussion regarding the limitations of surgery and continuing medical therapy and multidisciplinary treatments for pain after surgery should be had with the patient as part of preoperative counseling. Further, a discussion should take place that the finding of no endometriosis on laparoscopy and biopsy can help the physician and patient focus on identifying and treating other pain generators. The vast options for the medical suppression of endometriosis and the treatment of chronic pelvic pain are outside the scope of this manuscript but are nonetheless exceedingly important in the comprehensive management of the patient.
Both excision and ablation of endometriosis as a means of surgical treatment remain debated. A Cochrane systematic review showed an unclear benefit with excision vs ablation, although studies were extremely heterogeneous.6 Another systematic review showed significantly greater improvement in dysmenorrhea, dyschezia, and chronic pelvic pain with excision compared with ablation procedures.7
A recent study looking at complete peritoneal excision resulted in a high level of pain relief for patients with and without endometriosis.8 Although this study is new and not comparable with patients who did not undergo surgery, the findings may shed light on the physiologic reasons why excision of the peritoneum can result in some level of pain decrease. The authors recommend performing excision surgery, with the goal being histologic diagnosis and full excision of deeply infiltrative endometriosis.8 Because lesions appear heterogeneous or can be microscopic in nature, a true diagnosis cannot be made without a biopsy. With deeply infiltrative endometriosis, the lesions extend beyond the surface of the peritoneum and require a full excision to remove.
The location and depth of lesions impact the excisional technique and the procedures performed. Endometriotic lesions are commonly found on the uterosacral ligaments, posterior cul-de-sac, and rectovaginal septum.9 The typical appearance of an endometriosis lesion is a superficial “powder-burn” implant that can be black, dark brown, or red hemorrhagic spots. Deeply infiltrating endometriosis (DIE) invades greater than 5 mm into the surrounding organ or peritoneal surface.
Because implants can be associated with underlying fibrosis, adhesions, and distortion of adjacent anatomy, resection must be performed with a clear understanding of anatomic structures and relevant anatomic planes, including the pararectal, paravesical, rectovaginal, retrorectal, and retropubic spaces (Figure 1 and Table).
The surgeon should be comfortable with retroperitoneal dissection and both blunt and sharp dissection, with and without energy sources for lesions that lie on vital structures. Note: Because of the contractile nature of endometriosis, even early-stage disease may come close to retroperitoneal structures, including the ureter (Figure 2).
Complete resection results in decreased pain and recurrence compared with incomplete resection of lesions. Complete resection, however, is associated with increased complication rates, so cases involving advanced disease require meticulous technique by surgeons with substantial experience in complex endometriosis.10
Cul-de-sac lesions are common in patients diagnosed with endometriosis, especially DIE. The cul-de-sac or the pouch of Douglas is the peritoneal cavity between the rectum and the posterior uterus. Partial obliteration of the cul-de-sac can occur when fibrotic endometriosis has fused the rectum to the posterior vagina, or complete obliteration can occur when fibrotic endometriosis obscures the plane between the cervicovaginal junction and the rectum, usually involving the uterosacral ligaments (Figures 3 and 4).
Careful dissection is needed to avoid damaging the rectum and ureters. Opening the pararectal spaces on both sides can help in dissection and restoration of normal anatomy. To open the pararectal space, an incision can be made either medially or laterally to the infundibulopelvic ligament. The ureter can be found most superficially at the bifurcation of the common internal iliac artery, and starting the dissection at the pelvic brim—where the anatomy is less distorted—can be beneficial. Early identification of anatomic structures and pelvic vasculature allows the surgeon to limit bleeding and complications.
To resect lesions deep in the posterior cul-de-sac, the rectovaginal space can be entered at the uterosacral ligaments and generously developed below the fibrotic adhesions before attempting to divide them. The plane between the vagina and the rectum is avascular and can be separated with a combination of blunt and sharp dissection, up to the levator ani if necessary. Creating this plane allows the surgeon to identify the safest place to sharply divide the adhesions between the rectum and the cervix. Dilute vasopressin solution injected into the cervix and uterus prior to dissection can limit bleeding. Once the rectum has been carefully separated, the surgeon can focus on removing endometriotic implants from the vagina and cervix with electrosurgical devices (Figure 5).
Ovarian endometriomas occur in 17% to 44% of patients with endometriosis.11 When treating endometriomas, the goals are to reduce pain, exclude malignancy, improve fertility, and preserve ovarian function.
Endometriomas occur when menstrual debris builds up and becomes encapsulated within ovarian tissue. The cyst does not have an epithelial lining and is considered a pseudocyst, which can make removal more difficult. Options for treatment include drainage, ablation, cystectomy, and oophorectomy. Aspiration and fenestration with ablation are surgical options; however, because of high recurrence rates with aspiration and lower effectiveness at reducing pain and improving fertility with fenestration, excision is preferred.12
For women who desire ovarian conservation, ovarian cystectomy is favored. Use of vasopressin, hemostatic agents, and suturing to achieve hemostasis results in decreased collateral damage to surrounding ovary compared with electrosurgical methods. Oophorectomy is primarily performed if patients have recurrent cysts, are postmenopausal, or there is concern for malignancy. It is important to consider that bilateral oophorectomy without hormone replacement in those younger than 50 years plays a role in increasing risks of cardiovascular disease and all-cause mortality.
Endometriosis can affect the urinary system, and the bladder is the most affected site. In 36% of cases, the endometriosis is localized only to the bladder. Lesions generally evolve from the serosal surface to the mucosa, and the trigone and the dome are the most affected areas.13
Prior to surgical management, it is important to rule out vesical malignancy and identify the specific location of the lesion, including distance from the ureter. Complete resection of these lesions has been associated with decreased recurrence and significant reduction of pain.13
Treatment for the gynecologist typically involves partial cystectomy with full thickness incision. For lesions near the trigone, ureteral stents should be employed. Mobilization of the retropubic space can aid in visualization of the borders of the lesion. Closure of the cystotomy depends on the size of the lesion; however, as with repair of an inadvertent bladder injury, 2-layer closure using a 3-0 delayed absorbable suture can generally be utilized.14
When endometriosis involves the rectosigmoid colon, the depth of invasion should be assessed. Disease severity can vary greatly, from superficial adhesions to full-thickness disease that penetrates the mucosa. When gastrointestinal involvement is suspected, MRI, gel-contrast ultrasonography, and colonoscopy with endoscopic ultrasound can help assess colonic involvement. For severe disease—including cases with multiple bowel implants, sigmoid involvement, lesions greater than 3 cm, and lesions that involve greater than 50% of the bowel circumference, or in cases with bowel stenosis—resection with reanastomosis is beneficial.14
For more superficial cases, a shaving technique or discoid resection can be performed. A shaving technique can be implemented with sharp dissection of the implant down to the level of the muscularis. The bowel can then be oversewn perpendicular to the incision to avoid constriction of the bowel lumen. Barbed suture has been shown to be safe when suturing the bowel; however, traditional delayed absorbable sutures can also be used.15 In patients with smaller nodules that involve the mucosa, discoid resection can be considered, with closure in the same fashion.
In one study comparing the shaving technique, discoid resection, and segmental resection, the shaving group had a higher rate of recurrence of dysmenorrhea and dyspareunia, with similar rates of postoperative complications.
Lesions greater than 3 cm were associated with an increased risk of requiring bowel resection.16
Integrity of the bowel after a rectovaginal dissection or bowel resection should be confirmed. In a “bubble test,” air is injected retrograde into the rectum, the sigmoid is occluded at the sacral promontory, and the pelvis is filled with sterile irrigant. Observing bubbles indicates an opening that must be addressed to prevent postoperative bowel leakage into the peritoneal cavity.
Endometriosis of the abdominal wall is rare but expected to increase with rising cesarean section rates.17 In most studies, cesarean section was the inciting surgery; however, cases following laparotomy and port-site endometriosis have also been described, as well as cases in patients with no history of prior abdominal surgery. Some studies show concurrent pelvic endometriosis, whereas others describe cases with no associated pelvic lesions.17
Excision of the implant with complete margins is recommended to decrease risk of recurrence. Surgery may be booked with a general surgeon for closure if a large fascial defect is anticipated. Preoperative radioisotope injection to clearly identify small lesions has been described but is not well studied.18
Extrapelvic endometriosis is a rare condition, representing 8.9% of endometriotic cases. The most common sites include the gastrointestinal tract, urinary tract, and distant organs including the lung, abdominal wall, liver, gallbladder, and pancreas. Thoracic endometriosis syndrome, although rare, is the most frequent extrapelvic type of endometriosis. Catamenial pneumothorax (recurrent pneumothorax associated with menstruation) is a possible manifestation. Video-assisted thoracoscopic surgery to remove all endometriotic lesions and pleurectomy or pleurodesis are recommended
treatment strategies.19
Although surgical management of endometriosis is considered the gold standard for diagnosis and treatment of the disease, it should not be considered curative of all chronic pelvic pain. Pelvic pain can be both neuropathic and inflammatory in nature, with central sensitization of the nervous system and prefrontal cortex remodeling leading to continued pain even after excision of all endometriosis.2
Discouragingly, 30% of patients have chronic pain that is not responsive to surgery, and 50% develop recurrent symptoms within 5 years of treatment.5 One study found high pain recurrence rates after operative laparoscopy in patients aged 19 to 29 years, despite having no identifiable lesions on
repeat surgery.20
Patients with continued pain after surgery need comprehensive multidisciplinary management for their symptoms, including continued medical suppression of menses, consultations with pelvic floor physical therapists and pain interventionalists, and referrals to other subspecialists for the other organ systems involved.
To improve diagnosis of endometriosis and preoperative planning, imaging with an experienced sonographer can identify areas of endometriotic disease through site-specific tenderness, fixed ovaries, a negative “sliding sign,” and evidence of DIE nodules in the anterior and posterior compartments.21 Further, advances in MRI-acquisition protocols have improved diagnosis for DIE and enhancing lesions.22 Improved imaging can be diagnostic and also provide guidance for the surgeon in removing all the disease.
Endometriosis is a heterogeneous disease that inflicts a significant quality-of-life and cost burden on patients. Laparoscopy remains the gold standard for diagnosis and treatment. Although it is not curative for all chronic pelvic pain, laparoscopy should be a start in the approach to patients with suspicious symptoms. We recommend a comprehensive work-up for all causes of pelvic pain, and when endometriosis is suspected, preoperative planning with imaging, when applicable, and excision of all disease. When DIE is suspected, treatment should include referral to a subspecialist with experience in complex endometriosis.
wReferences
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More